UBS AM’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $978 | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $497K | Sell |
|
|||||
|
2024
Q2 | $618K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $75.1K | Hold |
|
|||||
|
2023
Q2 | $202K | Hold |
|
|||||
|
2023
Q1 | $202K | Sell |
|
|||||
|
2022
Q4 | $789K | Sell |
|
|||||
|
2022
Q3 | $9.21M | Sell |
|
|||||
|
2022
Q2 | $12.7M | Buy |
|
|||||
|
2022
Q1 | $17.2M | Buy |
|
|||||
|
2021
Q4 | $25M | Buy |
|
|||||
|
2021
Q3 | $21.3M | Buy |
|
|||||
|
2021
Q2 | $29.8M | Buy |
|
|||||
|
2021
Q1 | $24.7M | Sell |
|
|||||
|
2020
Q4 | $37.3M | Sell |
|
|||||
|
2020
Q3 | $22.7M | Buy |
|
|||||
|
2020
Q2 | $19.1M | Buy |
|
|||||
|
2020
Q1 | $8.14M | Sell |
|
|||||
|
2019
Q4 | $10.8M | Buy |
|
|||||
|
2019
Q3 | $8.56M | Buy |
|
|||||
|
2019
Q2 | $10.9M | Buy |
|
|||||
|
2019
Q1 | $9.34M | Buy |
|
|||||
|
2018
Q4 | $6.59M | Buy |
|
|||||
|
2018
Q3 | $1.07M | Buy |
|